<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02407626</url>
  </required_header>
  <id_info>
    <org_study_id>STZ-IFA-0115</org_study_id>
    <nct_id>NCT02407626</nct_id>
  </id_info>
  <brief_title>Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery</brief_title>
  <acronym>OPT</acronym>
  <official_title>Optimierung Der Kardioprotektion Durch Inhalative Anästhetika Eine Untersuchung Bei Patienten Mit Diabetes Mellitus während Off-pump Herzchirurgie</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Triemli Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Triemli Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the myocardial protection against perioperative ischemia comparing two
      standard anesthetic regimes in diabetic patients undergoing elective cardiac surgery. Half of
      the patients will receive volatile anesthesia while the other half will receive total
      intravenous anesthesia. Primary and secondary outcome parameters will be assessed after
      induction of anesthesia, at the end of the procedure and postoperative day 1 to 3.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Volatile anaesthetics such as Sevoflurane have shown to have a protective effect regarding
      myocardial ischemia in the perioperative setting - the so-called &quot;preconditioning&quot;. However
      the observed response of preconditioning in clinical trials is not consistent.

      An increased perioperative insulin resistance especially in diabetic patients resulting in an
      increased postoperative morbidity and mortality may be responsible for these findings.

      In an animal model, the use of propofol that is being routinely applied for general
      anesthesia was associated with a change of the insulin receptor substrate via phosphorylation
      and thus a change of insulin resistance.

      Avoiding a total intravenous anesthesia and applying a volatile anesthesia may result in an
      increased cardioprotective effect by a reduction of the perioperative insulin resistance.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Very low patient recruitment, changed insurance requirements
  </why_stopped>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">March 7, 2018</completion_date>
  <primary_completion_date type="Actual">March 7, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biomarker NT-proBNP</measure>
    <time_frame>1. after induction of anesthesia 2. after chest closure 3.-5. postoperative day 1, day 2, day 3</time_frame>
    <description>Difference between volatile anesthesia and total intravenous anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Receptor Substrate phosphorylization (IRS-1)/PP2A</measure>
    <time_frame>1. beginning of cardiac surgery, 2. end of cardiac surgery</time_frame>
    <description>Difference between volatile anesthesia and total intravenous anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of TNF/IL1beta and microRNA (miR144, miR125b, miR208a)</measure>
    <time_frame>1. beginning of cardiac surgery, 2. end of cardiac surgery</time_frame>
    <description>Difference between volatile anesthesia and total intravenous anesthesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volatile anesthesia for elective cardiac surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total intravenous anesthesia for elective cardiac surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Total intravenous anesthesia is a clinical standard procedure</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Volatile anesthesia is a clinical standard procedure</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes

          -  Elective cardiac surgery

        Exclusion Criteria:

          -  Emergency procedures

          -  Preop myocardial infarction

          -  Preop cardiac failure

          -  Preop renal replacement therapy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Zollinger, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Anesthesiology and Intensive Care Medicine Triemli City Hospital Zurich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Triemli City Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8063</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003 Jun;98(6):1315-27.</citation>
    <PMID>12766638</PMID>
  </reference>
  <reference>
    <citation>Lucchinetti E, Hofer C, Bestmann L, Hersberger M, Feng J, Zhu M, Furrer L, Schaub MC, Tavakoli R, Genoni M, Zollinger A, Zaugg M. Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology. 2007 Mar;106(3):444-57.</citation>
    <PMID>17325502</PMID>
  </reference>
  <reference>
    <citation>Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, Cornu C, Lecharny JB, Aussage P, Vicaut E, Pons A, Lehot JJ. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial. Br J Anaesth. 2007 Nov;99(5):624-31. Epub 2007 Oct 3.</citation>
    <PMID>17913754</PMID>
  </reference>
  <reference>
    <citation>Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth. 2003 Oct;91(4):551-65. Review.</citation>
    <PMID>14504159</PMID>
  </reference>
  <reference>
    <citation>Zaugg M, Lucchinetti E, Garcia C, Pasch T, Spahn DR, Schaub MC. Anaesthetics and cardiac preconditioning. Part II. Clinical implications. Br J Anaesth. 2003 Oct;91(4):566-76. Review.</citation>
    <PMID>14504160</PMID>
  </reference>
  <reference>
    <citation>Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007 Aug 18;370(9587):575-9.</citation>
    <PMID>17707752</PMID>
  </reference>
  <reference>
    <citation>Lou PH, Lucchinetti E, Zhang L, Affolter A, Gandhi M, Zhakupova A, Hersberger M, Hornemann T, Clanachan AS, Zaugg M. Propofol (Diprivan®) and Intralipid® exacerbate insulin resistance in type-2 diabetic hearts by impairing GLUT4 trafficking. Anesth Analg. 2015 Feb;120(2):329-40. doi: 10.1213/ANE.0000000000000558.</citation>
    <PMID>25437926</PMID>
  </reference>
  <reference>
    <citation>Whittington RA, Virág L, Marcouiller F, Papon MA, El Khoury NB, Julien C, Morin F, Emala CW, Planel E. Propofol directly increases tau phosphorylation. PLoS One. 2011 Jan 31;6(1):e16648. doi: 10.1371/journal.pone.0016648.</citation>
    <PMID>21304998</PMID>
  </reference>
  <reference>
    <citation>Swart MJ, De Jager WH, Kemp JT, Nel PJ, Van Staden SL, Joubert G. The effect of the metabolic syndrome on the risk and outcome of coronary artery bypass graft surgery. Cardiovasc J Afr. 2012 Aug;23(7):400-4. doi: 10.5830/CVJA-2012-055.</citation>
    <PMID>22914999</PMID>
  </reference>
  <reference>
    <citation>Wang L, Ko KW, Lucchinetti E, Zhang L, Troxler H, Hersberger M, Omar MA, Posse de Chaves EI, Lopaschuk GD, Clanachan AS, Zaugg M. Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift. Anesthesiology. 2010 Sep;113(3):541-51. doi: 10.1097/ALN.0b013e3181e2c1a1.</citation>
    <PMID>20683255</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2015</study_first_submitted>
  <study_first_submitted_qc>March 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2015</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Triemli Hospital</investigator_affiliation>
    <investigator_full_name>Christoph K Hofer</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>ischemia</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>volatile anesthetic</keyword>
  <keyword>total intravenous anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

